Apatinib enhances chemosensitivity of ABT‐199 in diffuse large B‐cell lymphoma

To investigate the effect of Apatinib (an inhibitor targeting VEGFR‐2) enhances chemosensitivity of ABT‐199 on diffuse large B‐cell lymphoma (DLBCL). Viability assay and flow cytometric assay for determining apoptosis, cell cycle, mitochondrial membrane potential, reactive oxygen species and immunob...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yuanfei, Ye, Jing, Shen, Huafei, Xu, Yi, Wan, Rui, Ye, Xiujin, Jin, Jie, Xie, Wanzhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580892/
https://www.ncbi.nlm.nih.gov/pubmed/36053810
http://dx.doi.org/10.1002/1878-0261.13309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580892/
https://www.ncbi.nlm.nih.gov/pubmed/36053810
http://dx.doi.org/10.1002/1878-0261.13309

Ejemplares similares